Back ground: Tuberculosis (TB) is the leading cause of death among HIV infected patients. About one third of HIV infected patients are co-infected with TB and most of them are living in low and middle income countries. HIV is the most powerful risk factor known for activation of latent mycobacterium tuberculosis (MBT) infection. Objective: To determine the prevalence of TB co-infection and associated factors among HIV patients attending anti-retroviral therapy (ART). Method: An institution based cross-sectional study was conducted at ART clinic of Jimma University Specialized teaching Hospital (JUSTH) from March to April 2016. A convenient sampling technique was used to collect data from each study participant. Data were collected by tr...
Background. Tuberculosis (TB) notification in South Africa has increased six-fold over the past two ...
Tuberculosis and human Immuno-deficiency virus co-epidemics remain a major public health challenge p...
Data on the clinical presentations and magnitude of tuberculosis (TB)-human immunodeficiency virus (...
Background: Tuberculosis is one of the world\u2019s most common causes of death in the era of Human ...
Background: Tuberculosis is one of the world’s most common causes of death in the era of Human immun...
Background: TB/HIV co-infection is a major public health problem in many parts of the world. But the...
Purpose: The purpose of this study is to assess risk factors associated with TB co-infection in HIV/...
The objective of this study was to estimate HIV infection and associated risk factors among smear po...
Introduction: initiation of antiretroviral therapy (ART) and co-trimoxazole preventive therapy (CPT)...
Background: Diseases and conditions that weaken immunity, such as malnutrition, smoking, alcoholism,...
Background/aim: Tuberculosis (TB) is one of the most common chronic infectious conditions causing mo...
Background: Tuberculosis (TB) and HIV co-infection causes a heavy burden on health care systems and ...
Background: A complex interaction exists between tuberculosis (TB) and human immunodeficiency virus ...
Abstract Objective The study aimed to determine the prevalence and identify determinants of TB among...
Background: Tuberculosis and Human Immunodeficiency Virus (HIV) co-infection is a major problem in N...
Background. Tuberculosis (TB) notification in South Africa has increased six-fold over the past two ...
Tuberculosis and human Immuno-deficiency virus co-epidemics remain a major public health challenge p...
Data on the clinical presentations and magnitude of tuberculosis (TB)-human immunodeficiency virus (...
Background: Tuberculosis is one of the world\u2019s most common causes of death in the era of Human ...
Background: Tuberculosis is one of the world’s most common causes of death in the era of Human immun...
Background: TB/HIV co-infection is a major public health problem in many parts of the world. But the...
Purpose: The purpose of this study is to assess risk factors associated with TB co-infection in HIV/...
The objective of this study was to estimate HIV infection and associated risk factors among smear po...
Introduction: initiation of antiretroviral therapy (ART) and co-trimoxazole preventive therapy (CPT)...
Background: Diseases and conditions that weaken immunity, such as malnutrition, smoking, alcoholism,...
Background/aim: Tuberculosis (TB) is one of the most common chronic infectious conditions causing mo...
Background: Tuberculosis (TB) and HIV co-infection causes a heavy burden on health care systems and ...
Background: A complex interaction exists between tuberculosis (TB) and human immunodeficiency virus ...
Abstract Objective The study aimed to determine the prevalence and identify determinants of TB among...
Background: Tuberculosis and Human Immunodeficiency Virus (HIV) co-infection is a major problem in N...
Background. Tuberculosis (TB) notification in South Africa has increased six-fold over the past two ...
Tuberculosis and human Immuno-deficiency virus co-epidemics remain a major public health challenge p...
Data on the clinical presentations and magnitude of tuberculosis (TB)-human immunodeficiency virus (...